Zhijian Cao Selected Research

Kv1.2 Potassium Channel

1/2021

BmK86-P1, a New Degradation Peptide with Desirable Thermostability and Kv1.2 Channel-Specific Activity from Traditional Chinese Scorpion Medicinal Material.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhijian Cao Research Topics

Disease

16	Infections 06/2022 - 01/2011
7	COVID-19 06/2022 - 01/2020
6	Virus Diseases (Viral Diseases) 01/2022 - 09/2015
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2011
4	Bacterial Infections (Bacterial Infection) 02/2021 - 11/2008
4	Neoplasms (Cancer) 01/2021 - 05/2010
3	Parkinson Disease (Parkinson's Disease) 01/2017 - 01/2005
3	Glioma (Gliomas) 02/2016 - 05/2010
2	Inflammation (Inflammations) 06/2022 - 01/2021
2	Epilepsy (Aura) 01/2021 - 01/2005
2	Hypersensitivity (Allergy) 01/2019 - 03/2017
2	Channelopathies 01/2018 - 01/2013
2	Measles 01/2012 - 07/2011
1	Post-Acute COVID-19 Syndrome 05/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Pain (Aches) 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Colitis 01/2022
1	Wound Infection (Wound Infections) 02/2021
1	Bites and Stings (Sting) 01/2021
1	Tick Bites 01/2021
1	Ataxia (Dyssynergia) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Pruritus (Itching) 01/2021
1	Severe Fever with Thrombocytopenia Syndrome 01/2020
1	Cicatrix (Scar) 05/2019
1	Edema (Dropsy) 05/2019
1	Fibrosis (Cirrhosis) 05/2019
1	Wounds and Injuries (Trauma) 05/2019
1	Gram-Positive Bacterial Infections 01/2018
1	Onychomycosis (Tinea Unguium) 01/2018
1	Peritonitis 01/2018
1	Bacteremia 01/2018
1	Ascites 01/2018
1	Motor Disorders 01/2017
1	Peripheral Nerve Injuries 01/2017
1	Bell Palsy (Bell's Palsy) 01/2017
1	Hepatitis B 03/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2015

Drug/Important Bio-Agent (IBA)

18	Peptides (Polypeptides)IBA 01/2021 - 02/2007
10	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
8	Scorpion Venoms (Scorpion Venom)IBA 12/2018 - 07/2011
7	VaccinesIBA 06/2022 - 01/2019
6	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 11/2011
4	DefensinsIBA 01/2021 - 12/2017
3	Ion Channels (Ion Channel)IBA 01/2021 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2012
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Biological ProductsIBA 10/2020 - 11/2008
2	Vitamin D FDA LinkGeneric 10/2020 - 01/2020
2	VenomsIBA 01/2020 - 02/2014
2	Interleukin-2 (IL2)IBA 01/2019 - 02/2015
2	InterferonsIBA 12/2018 - 01/2016
2	PotassiumIBA 01/2017 - 01/2013
2	ChlorotoxinIBA 02/2016 - 11/2010
2	Chloride Channels (Chloride Channel)IBA 02/2016 - 05/2010
2	gamma-Aminobutyric Acid (GABA)IBA 02/2008 - 10/2007
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 02/2008 - 01/2005
1	Angiotensin Receptor AntagonistsIBA 03/2022
1	AcidsIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2021
1	Bacterial ToxinsIBA 02/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	CalciumIBA 01/2021
1	CytokinesIBA 01/2021
1	Salivary Proteins and PeptidesIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	capivasertibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021
1	Kv1.2 Potassium ChannelIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Hormones (Hormone)IBA 10/2020
1	25-hydroxyvitamin DIBA 10/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	SB 203580IBA 01/2020
1	CarrageenanIBA 05/2019
1	CollagenIBA 05/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2019
1	Hematoxylin (Haematoxylon)IBA 05/2019
1	Transcription Factor 3IBA 12/2018
1	Interferon Type IIBA 12/2018
1	LuciferasesIBA 12/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Anti-Infective Agents (Microbicides)IBA 06/2016
1	Antimicrobial PeptidesIBA 06/2016
1	Immunologic Factors (Immunomodulators)IBA 04/2016
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2016
1	Hepatitis B e AntigensIBA 03/2016
1	NucleotidesIBA 01/2016

Therapy/Procedure

8	Therapeutics 05/2022 - 05/2010
2	Lasers (Laser) 02/2021 - 11/2010
2	Intravenous Injections 03/2016 - 08/2012
1	Electroacupuncture 01/2022
1	Photothermal Therapy 02/2021